Jump to content
Knowledge Hub

News Archive

EMA Management Board Highlights: October 2025

10th October 2025

The European Medicines Agency (EMA) Management Board convened on 2nd October 2025, reviewing mid-year performance and endorsing strategic initiatives.

Read More+

EMA Seeks Public Input on Enhancing Patient Perspectives in Medicine Regulation

10th October 2025

The European Medicines Agency (EMA) has released a draft reflection paper inviting public consultation on integrating patient experience data into the regulatory process.

Read More+

EMA's PRAC Meeting Highlights: 29th September – 2nd October 2025

10th October 2025

The European Medicines Agency’s Pharmacovigilance Risk Assessment Committee (PRAC) convened from 29th September to 2nd October 2025, addressing various aspects of medicine safety.

Read More+

FDA Issues Final Guidance on Assessing Drug Manufacturing Facilities Using Alternative Tools

10th October 2025

The FDA has finalised guidance on employing alternative tools to evaluate drug manufacturing facilities in pending applications.

Read More+

MHRA Patient Safety Essay Competition 2025

10th October 2025

The MHRA invites medical students and foundation doctors to explore how genetics can enhance prescribing safety and patient outcomes in the UK.

Read More+

MHRA Updates Guidance on Clinical Trials Involving In Vitro Diagnostic Devices

10th October 2025

The MHRA has released updated guidance for conducting clinical trials that include in vitro diagnostic (IVD) devices.

Read More+

MHRA Updates Guidance on Clinical Trials Requiring Expert Advice

10th October 2025

The MHRA has released updated guidance for clinical trials that necessitate expert advice from specialist groups or committees.

Read More+

MHRA Updates Guidance on Clinical Trials: Collection, Verification, and Reporting of Safety Events

10th October 2025

The MHRA has released an updated version of its guidance on safety event management in clinical trials.

Read More+

MHRA Updates Guidance on Ending Clinical Trials

10th October 2025

The MHRA has released updated guidance on the process for ending clinical trials, effective from 28th April 2026.

Read More+

MHRA Updates Guidance on Modifying Clinical Trial Approvals: Introduction of Route A and B Processes

10th October 2025

The MHRA has updated its guidance on modifying clinical trial approvals, introducing Route A and B processes to streamline amendments.

Read More+
« Previous | Page 5 of 124 | Next »

Share